Research & Development In Brief
This article was originally published in The Tan Sheet
Executive Summary
Daily aspirin lowers the risk of cancers
You may also be interested in...
Research & Development In Brief
Low-dose aspirin reduces colorectal cancer
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.